Financial reports
10-Q
2024 Q2
Quarterly report
13 Mar 24
ARS
2023 FY
Annual report to shareholders
21 Dec 23
10-Q
2024 Q1
Quarterly report
15 Dec 23
10-K/A
2023 FY
Annual report (amended)
28 Nov 23
10-K
2023 FY
Annual report
3 Nov 23
NT 10-K
Notice of late annual filing
30 Oct 23
10-Q
2023 Q3
Quarterly report
14 Jun 23
NT 10-Q
Notice of late quarterly filing
9 Jun 23
10-Q
2023 Q2
Quarterly report
20 Mar 23
NT 10-Q
Notice of late quarterly filing
14 Mar 23
Current reports
8-K
Enzo Biochem Reports Second Quarter Fiscal 2024 Results and Provides Business Update
13 Mar 24
8-K
Departure of Directors or Certain Officers
27 Feb 24
8-K
Enzo Biochem Reports Results of its Annual Meeting of Shareholders and Officer Appointments
1 Feb 24
8-K
Departure of Directors or Certain Officers
30 Oct 23
8-K
Enzo Biochem Announces Departure of Hamid Erfanian and Appointment of Kara Cannon as Interim CEO
6 Sep 23
8-K/A
Financial Statements and Exhibits
28 Jul 23
8-K
Enzo Biochem Completes Sale of Clinical Laboratory to Labcorp
24 Jul 23
8-K
Other Events
17 Jul 23
8-K
Entry into a Material Definitive Agreement
10 Jul 23
8-K
Other Events
16 Jun 23
Registration and prospectus
424B3
Prospectus supplement
18 Jul 23
S-3/A
Shelf registration (amended)
18 Jul 23
S-3/A
Shelf registration (amended)
10 Jul 23
424B3
Prospectus supplement
21 Jun 23
S-3/A
Shelf registration (amended)
16 Jun 23
S-3
Shelf registration
16 Jun 23
D
$7.00 mm in options, sold $7.00 mm, 3 investors
2 Jun 23
S-3/A
Shelf registration (amended)
26 May 23
S-3
Shelf registration
12 May 23
S-8
Registration of securities for employees
9 Nov 21
Proxies
DEFR14A
Revised proxy
21 Dec 23
DEFA14A
Additional proxy soliciting materials
8 May 23
DEFA14A
Additional proxy soliciting materials
24 Apr 23
DEFM14A
Proxy related to merger
24 Apr 23
PREM14A
Preliminary proxy related to merger
12 Apr 23
DEFA14A
Additional proxy soliciting materials
16 Mar 23
DEFR14A
Revised proxy
20 Dec 22
DEF 14A
Definitive proxy
20 Dec 22
DEFA14A
Additional proxy soliciting materials
6 Apr 22
DEFA14A
Additional proxy soliciting materials
1 Apr 22
Other
EFFECT
Notice of effectiveness
19 Jul 23
CORRESP
Correspondence with SEC
18 Jul 23
CORRESP
Correspondence with SEC
18 Jul 23
UPLOAD
Letter from SEC
14 Jul 23
CORRESP
Correspondence with SEC
10 Jul 23
UPLOAD
Letter from SEC
28 Jun 23
EFFECT
Notice of effectiveness
22 Jun 23
CORRESP
Correspondence with SEC
20 Jun 23
CORRESP
Correspondence with SEC
9 Jun 23
UPLOAD
Letter from SEC
22 May 23
Ownership
4
Kara Cannon
27 Feb 24
4
Patricia Eckert
27 Feb 24
SC 13G/A
1 MAIN CAPITAL MANAGEMENT, LLC
14 Feb 24
SC 13G/A
RENAISSANCE TECHNOLOGIES LLC
13 Feb 24
4
STEVEN J PULLY
2 Feb 24
4
MARY TAGLIAFERRI
2 Feb 24
4
Bradley Louis Radoff
2 Feb 24
4
STEVEN J PULLY
15 Dec 23
3
STEVEN J PULLY
30 Oct 23
SC 13G
1 MAIN CAPITAL MANAGEMENT, LLC
11 Sep 23